loading
Schlusskurs vom Vortag:
$32.71
Offen:
$33.08
24-Stunden-Volumen:
59,542
Relative Volume:
0.09
Marktkapitalisierung:
$1.88B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-100.44M
KGV:
-14.75
EPS:
-2.1478
Netto-Cashflow:
$-105.32M
1W Leistung:
-15.27%
1M Leistung:
-17.73%
6M Leistung:
-10.82%
1J Leistung:
-37.78%
1-Tages-Spanne:
Value
$31.82
$33.75
1-Wochen-Bereich:
Value
$29.48
$37.76
52-Wochen-Spanne:
Value
$26.61
$66.38

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name
Firmenname
Structure Therapeutics Inc Adr
Name
Telefon
(628) 229-9277
Name
Adresse
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Name
Mitarbeiter
148
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GPCR's Discussions on Twitter

Vergleichen Sie GPCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
GPCR 31.92 1.88B 0 -100.44M -105.32M -2.1478
VRTX 447.21 115.74B 10.63B -479.80M -1.35B 13.33
REGN 737.75 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 586.52 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.92 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.55 24.49B 3.30B -501.07M 1.03B 11.54

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-21 Eingeleitet JP Morgan Overweight
2024-04-09 Eingeleitet Cantor Fitzgerald Overweight
2023-10-19 Eingeleitet JMP Securities Mkt Outperform
2023-07-27 Eingeleitet Piper Sandler Overweight
2023-05-25 Fortgesetzt Jefferies Buy
2023-02-28 Eingeleitet BMO Capital Markets Outperform
2023-02-28 Eingeleitet Guggenheim Buy
2023-02-28 Eingeleitet Jefferies Buy
2023-02-28 Eingeleitet SVB Securities Outperform
Alle ansehen

Structure Therapeutics Inc Adr Aktie (GPCR) Neueste Nachrichten

pulisher
Nov 20, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Assetmark Inc. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Nov 19, 2024
pulisher
Nov 18, 2024

FY2024 Earnings Forecast for GPCR Issued By Lifesci Capital - Defense World

Nov 18, 2024
pulisher
Nov 17, 2024

GPCRStructure Therapeutics Inc. American Depositary Shares Latest Stock News & Market Updates - StockTitan

Nov 17, 2024
pulisher
Nov 16, 2024

Structure Therapeutics (NASDAQ:GPCR) Trading Down 8.9%Here's What Happened - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Structure Therapeutics to Present at Jefferies London Healthcare Conference | GPCR Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 14, 2024

GSA Capital Partners LLP Purchases Shares of 30,464 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Structure Therapeutics Reports Strong Q3 2024 Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Structure Therapeutics Advances Obesity Drug Trial, Reports $915M Cash Position | GPCR Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Structure Therapeutics Launches Phase 2b Obesity Drug Trial, Expands Testing to Higher Doses | GPCR Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 05, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Is Viking Therepautics a Buy Now? - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Oral Proteins and Peptides Market to Reach $28.17 Billion by 2031 As Revealed In New Report - WhaTech

Nov 05, 2024
pulisher
Nov 05, 2024

Some of the Major Key Players in the oral proteins and peptides market are - InsightAce Analytic

Nov 05, 2024
pulisher
Nov 03, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Position Increased by abrdn plc - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Ballard Power Systems Inc (NASDAQ: BLDP) Has Great Upside Potential - Stocks Register

Nov 01, 2024
pulisher
Nov 01, 2024

Is Structure Therapeutics Inc ADR (NASDAQ: GPCR) A Good Investment For New Investors Now? - Stocks Register

Nov 01, 2024
pulisher
Oct 31, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

Biopharma Co. Can't Knock Ex-CFO's Bias Suit Out Of Court - Law360

Oct 30, 2024
pulisher
Oct 30, 2024

Armata Pharmaceuticals Announces Structural Biology Publication - StockTitan

Oct 30, 2024
pulisher
Oct 28, 2024

Secretome Therapeutics, Inc. Announces Composition of Matter Patents for Lead Assets STM-01 and STM-21 - Business Wire

Oct 28, 2024
pulisher
Oct 26, 2024

Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $86.80 - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

GPCR drugmaker Septerna amasses $288M in IPO - BioPharma Dive

Oct 24, 2024
pulisher
Oct 17, 2024

Griffin Asset Management Inc. Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Structure Therapeutics Inc ADR (GPCR) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Exchange Traded Concepts LLC Has $1.80 Million Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Structure Therapeutics Inc ADR Inc. (GPCR) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

Daily Progress: Structure Therapeutics Inc ADR (GPCR) Drop -1.39, Closing at 38.32 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Is Structure Therapeutics Inc ADR (GPCR) a threat to investors? - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Down 2.7%Here's What Happened - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Structure Therapeutics Inc ADR: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Top investors say Structure Therapeutics Inc ADR (GPCR) ticks everything they need - SETE News

Oct 10, 2024
pulisher
Oct 10, 2024

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch. - BioPharma Dive

Oct 10, 2024
pulisher
Oct 10, 2024

Weight Loss Drugs Market Top Trends 2024-2031 - InsightAce Analytic

Oct 10, 2024
pulisher
Oct 09, 2024

Market Recap Check: Structure Therapeutics Inc ADR (GPCR)’s Positive Finish at 40.50, Up/Down 0.30 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect? - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Up 3.7%Here's What Happened - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

The Manufacturers Life Insurance Company Buys 32,839 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Structure Therapeutics Inc ADR (GPCR) is a good investment, but the stock may be overvalued - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

27,094 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Bank of Montreal Can - MarketBeat

Oct 07, 2024
pulisher
Oct 05, 2024

35,700 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Renaissance Technologies LLC - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

Marshall Wace LLP Raises Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

3 AI Stocks to Buy as Nvidia Sputters - InvestorPlace

Oct 04, 2024
pulisher
Oct 02, 2024

Are Structure Therapeutics Inc ADR (GPCR) shares a good deal now? - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% Higher - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

GentiBio Appoints Mark Bach, M.D., Ph.D., as Chief Medical Officer - BioSpace

Sep 30, 2024
pulisher
Sep 30, 2024

Nasdaq Global Select Market Composite Index (NQGS) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

S&P 100 Index (OEX) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 30, 2024

Finanzdaten der Structure Therapeutics Inc Adr-Aktie (GPCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):